Literature DB >> 31759282

Cytofluorimetric and immunohistochemical comparison for detecting bone marrow infiltration in non-Hodgkin lymphomas: a study of 354 patients.

Teodora Statuto1, Luciana Valvano2, Giovanni Calice3, Oreste Villani4, Giuseppe Pietrantuono4, Giovanna Mansueto4, Giovanni D'Arena4, Giulia Vita5, Vittoria Lalinga5, Luciana Possidente2, Luigi Del Vecchio6, Fiorella D'Auria2, Pellegrino Musto7.   

Abstract

Morphological and immunohistochemical (IHC) analysis of bone marrow biopsies (BMB) is routinely performed during staging of patients with non-Hodgkin's lymphoma (NHL). Aiming to evaluate the possible diagnostic value of flow cytometry (FC) on bone marrow aspirates (BMA), as compared with BMB, we retrospectively reviewed BMA specimen of 354 NHL. In 305 cases (86.1 %), there was a concordance between the two investigations. A discordance was detected in 49 cases (14 %): in 33 of these (9.3 % of total population), FC analysis of BMA was positive, whereas BMB, supported by IHC, was negative; in 16 (4.5 % of total population), FC did not detected lymphoid infiltration, while BMB was positive. Although the clinical implications of such an observation remain unclear, we think our results may be useful in the context of current staging procedures, also opening a possible future perspective in the setting of minimal measurable disease in these patients.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  Bone marrow infiltration; Flow cytometry; Immunohistochemical analysis; Immunophenotyping; Non-Hodgkin’s lymphoma

Mesh:

Year:  2019        PMID: 31759282     DOI: 10.1016/j.leukres.2019.106267

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  1 in total

1.  Aberrant expression of CD54 detected by flow cytometry is a characteristic of B-lymphoma cells in bone marrow specimens.

Authors:  Wei Wang; Yan Li; Haval Ali; Linjun Zhao; Di Mei; Wenqing Hu; Bin Jiang
Journal:  BMC Cancer       Date:  2021-12-08       Impact factor: 4.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.